Assessing the Anti-Epileptic and Anti-Nociceptive Potentials of Pepperomia pellucida in Pentylenetetrazol-Induced Epileptic Seizure in Mice
Main Article Content
Abstract
Background: Epilepsy has become one of the major public health problems in the world is characterized by seizures resulting from abnormal electrical discharges in the brain. Hence, this study to assess the anti-epileptic and antinoceptive potentials of Pepperomia pellucida in pentylenetetrazol-induced epileptic mice model. Methods: Forty (40) Swiss male albino mice weighing 21 to 35kg were randomly assigned into four groups (A to D) ten mice each and treated as follows: Group A served as the control, Group B received pentylenetetrazol 35mg/kg intraperitoneally, Group C received pentylenetetrazol 35mg/kg intraperitoneally + peperomia pellucida 2mg/kg orally, and Group D received pentylenetetrazol 35mg/kg intraperitoneally + Diazepam 0.001ml/kg orally. Pentylenetetrazol 35mg/kg intraperitoneally was used to induce epilepsy and the animals were considered epileptic after few minutes with a jerky movement of the tail and limb progressing to the entire body. All animals had access to food and water ad libitum. After administration for 14 days, epilepsy was induced and then neurobehavioral studies for nociception was assessed using the formalin test. Results: pentylenetetrazol 35mg/kg had significant epileptic seizures scores as evidenced by increased duration of seizures, frequency of jerks, onset of tonic seizures and onset of seizures and also had significant edema of the animals’ paw. Peperomia pellucida significantly ameliorated the epileptic seizure and reduced the edema of the animals’ paw induced by the pentylenetetrazol. IBM SPSS statistical software version 20, was used to analyze the data p<0.001. Conclusions: It is based on these results, we draw the conclusion that Peperomia pellucida may possess anti-epileptic and anti-nociceptive properties that resulted in the significant reduction in the epileptic seizures and edema of the animals’ paw in the Peperomia pellucida treated group.
Downloads
Article Details

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Blond BN, Detyniecki K, Hirsch LJ (2016). Assessment of treatment side effects and quality of life in people with epilepsy. Neurol clin. 34:395-viii
Chakraborty P, Sanchez NA, Kaddumukasa M, kajumba M, Kakooza-Mwesige A, Van Noord M (2021). Stigma reduction interventions for epilepsy: a systematized literature review. Epilepsy behav.114:107381
De Fatima ABM, Dmitrieva EG, Franzotti EM (2004). Anti-inflammatory and analgesic activity of Peperomia pellucida (L) HBK (piperaceae). Journal of ethnopharmacol 91(2-3):215-218. Epub 2004/05/04.10.1016/j.jp.2003.12.030
Egwuche, RU, AA. Odetola and OL, Erukainure (2011). Preliminary investigation into the chemical properties of Peperomia pellucida (L) Phytochemistry, 5(1): 48-53
Grootendorst, A. T., &Kasteleijn-NolstTrenité, D. G. (2013). Management of convulsive and nonconvulsive status epilepticus. Epileptic Disorders, 15(2), 117-131.
Kaddumukasa M, Kakooza A, Kayima J, Kaddumukasa MN, Ddumba E, Mugenyi L (2016). Community knowledge of and attitude toward epilepsy in rural and urban Mukono district, Uganda: a cross sectional study. Epilepsy behav. 54:7-11
Kaminska, K., King, M. A., & Uteshev, V. V. (2013). A mechanistic target-based approach to drug discovery for epileptic encephalopathy. Expert Opinion on Therapeutic Targets, 17(9), 1027-1044
Kim SJ, kim HJ, Jon JY, kim HW, Lee SA (2020). Clinical factors associated with suicide risk independent of depression in persons with epilepsy. Seizure 80:86-91
Löscher, W., & Schmidt, D. (2011). Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Epilepsia, 52(4), 657-678.
Mosaku KS, Fatoye FO, Komolafe M, Lawal M, Ola BA (2006). Quality of life and associated factors among adults with epilepsy in Nigeria. Int. Journal of Psychiatric Medicine 36:469-81
Moura, D., Lopes-Junior, L., Cruz, J., Brito, M., Santos, V., Medeiros, J., &Citó, A. (2016). Anticonvulsant effects of the ethanolic extract from Peperomia pellucida. Journal of Ethnopharmacology, 177; 102-107.
Perucca, E., & Gilliam, F. (2012). Adverse effects of antiepileptic drugs. The Lancet Neurology, 11(9), 792-802.
Sawada LA, Monteiro VS, Rabelo GR, Dias GB, DA Cunha, M, DO, Nascimento JL (2014). Libidibia ferrea mature seeds promote antinoceptive effect by peripheral and central pathway: possible involvement of opioid and cholinergic receptors. Biomed. Res. Int. 2014:508725. Epub 2014/05/27.10.1155/2014/508725
Taylor RS, Sander JW, Taylor RJ, Baker GA. (2011). Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 52(12):2168-80
Thijis RD, Surges, R, O’brien TJ, Sander JW (2019). Epilepsy in adults. Lancet 393:689-701
Treiman, D. (2001). The role of the gamma-aminobutyric acid system in epilepsy. Epilepsia, 42 (suppl_3), 3-8.
Wei, LS, Wee W, Siong, J, Syamsumir DF (2011). Characterization of anticancer, antimicrobial, antioxidant properties and chemical composition of Peperomia pellucida leaf extract. Acta Medica irania, 49 (10): 670-674
Zhao Y, Wu H, Li J, Dong Y, Liang J, Zhu J (2011). Quality of life and related factors in adults’ patients with epilepsy in china. Epilepsy behav. 22:376-9




















